Annual Short Term Debt
$21.18 M
+$17.69 M+506.07%
December 1, 2024
Summary
- As of March 10, 2025, XERS annual short term debt is $21.18 million, with the most recent change of +$17.69 million (+506.07%) on December 1, 2024.
- During the last 3 years, XERS annual short term debt has risen by +$21.18 million (+100.00%).
- XERS annual short term debt is now at all-time high.
Performance
XERS Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$21.18 M
+$83.00 K+0.39%
December 31, 2024
Summary
- As of March 10, 2025, XERS quarterly short term debt is $21.18 million, with the most recent change of +$83.00 thousand (+0.39%) on December 31, 2024.
- Over the past year, XERS quarterly short term debt has stayed the same.
- XERS quarterly short term debt is now -99.38% below its all-time high of $3.43 billion, reached on March 31, 2018.
Performance
XERS Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
XERS Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +506.1% | 0.0% |
| 3 y3 years | +100.0% | +795.3% |
| 5 y5 years | - | +795.3% |
XERS Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | at high | -100.0% |
| 5 y | 5-year | at high | -100.0% | at high | -100.0% |
| alltime | all time | at high | -100.0% | -99.4% | -100.0% |
Xeris Biopharma Holdings Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $21.18 M(+0.4%) |
| Dec 2024 | $21.18 M(+506.1%) | - |
| Sep 2024 | - | $21.10 M(+297.6%) |
| Jun 2024 | - | $5.31 M(+14.8%) |
| Mar 2024 | - | $4.62 M(+32.3%) |
| Dec 2023 | $3.50 M(+121.2%) | $3.50 M(+47.7%) |
| Sep 2023 | - | $2.37 M(+22.3%) |
| Jun 2023 | - | $1.94 M(+33.6%) |
| Mar 2023 | - | $1.45 M(-8.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $1.58 M(>+9900.0%) | $1.58 M(+363.3%) |
| Mar 2022 | - | $341.00 K(>+9900.0%) |
| Dec 2021 | $0.00 | $0.00(-100.0%) |
| Jun 2019 | - | $3.00 M(-99.9%) |
| Mar 2019 | - | $2.58 B(+18.2%) |
| Dec 2018 | - | $2.19 B(-29.1%) |
| Sep 2018 | - | $3.08 B(-0.3%) |
| Jun 2018 | - | $3.09 B(-9.8%) |
| Mar 2018 | - | $3.43 B(+43.7%) |
| Dec 2017 | - | $2.39 B |
FAQ
- What is Xeris Biopharma Holdings annual short term debt?
- What is the all time high annual short term debt for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual short term debt year-on-year change?
- What is Xeris Biopharma Holdings quarterly short term debt?
- What is the all time high quarterly short term debt for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly short term debt year-on-year change?
What is Xeris Biopharma Holdings annual short term debt?
The current annual short term debt of XERS is $21.18 M
What is the all time high annual short term debt for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual short term debt is $21.18 M
What is Xeris Biopharma Holdings annual short term debt year-on-year change?
Over the past year, XERS annual short term debt has changed by +$17.69 M (+506.07%)
What is Xeris Biopharma Holdings quarterly short term debt?
The current quarterly short term debt of XERS is $21.18 M
What is the all time high quarterly short term debt for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly short term debt is $3.43 B
What is Xeris Biopharma Holdings quarterly short term debt year-on-year change?
Over the past year, XERS quarterly short term debt has changed by $0.00 (0.00%)